[Are all antihypertensive agents equal? Cardiovascular events in hypertensive patients randomized to treatment with doxazosin or chlorthalidone. The ALLHAT study].
Schillaci
G
G
Sezione di Medicina Interna, Angiologia e Malattie da Arteriosclerosi, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi, Perugia.
Verdecchia
P
P
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D017311:Amlodipine / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002170:Canada; D002752:Chlorthalidone / Q000627:therapeutic use; D003327:Coronary Disease / Q000401:mortality; D004232:Diuretics / Q000627:therapeutic use; D017292:Doxazosin / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D017706:Lisinopril / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D014481:United States
D000317:Adrenergic alpha-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D017311:Amlodipine; D017706:Lisinopril; D017292:Doxazosin; D002752:Chlorthalidone